Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models

Lianhua Bai; Donald P Lennon; Arnold I Caplan; Anne DeChant; Jordan Hecker; Janet Kranso; Anita Zaremba; Robert H Miller

doi:10.1038/nn.3109

journal article May 20, 2012

Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models

Lianhua Bai Donald P Lennon Arnold I Caplan Anne DeChant Jordan Hecker Janet Kranso Anita Zaremba Robert H Miller

Nature Neuroscience Vol. 15 No. 6 pp. 862-870 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nn.3109

Topics

No keywords indexed for this article. Browse by subject →

References

50

[1]

Prineas, J.W. The neuropathology of multiple sclerosis. in Handbook of Clinical Neurology (ed. Koestier, J.C.) 15–30 (Elsevier, Amsterdam, 1985).

[2]

Trapp, B.D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278–285 (1998). 10.1056/nejm199801293380502

[3]

Wolswijk, G. & Noble, M. Identification of an adult-specific glial progenitor cell. Development 105, 387–400 (1989). 10.1242/dev.105.2.387

[4]

Reynolds, B.A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707–1710 (1992). 10.1126/science.1553558

[5]

Ben-Hur, T. & Goldman, S.A. Prospects of cell therapy for disorders of myelin. Ann. NY Acad. Sci. 1142, 218–249 (2008). 10.1196/annals.1444.014

[6]

Uccelli, A., Pistoia, V. & Moretta, L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 28, 219–226 (2007). 10.1016/j.it.2007.03.001

[7]

Pluchino, S. et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422, 688–694 (2003). 10.1038/nature01552

[8]

Busch, S.A. et al. Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J. Neurosci. 30, 255–265 (2010). 10.1523/jneurosci.3705-09.2010

[9]

Mesenchymal stem cells as trophic mediators

Arnold I. Caplan, James E. Dennis

Journal of Cellular Biochemistry 2006 10.1002/jcb.20886

[10]

Lazarus, H.M. et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 11, 389–398 (2005). 10.1016/j.bbmt.2005.02.001

[11]

Yoo, S.W. et al. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp. Mol. Med. 40, 387–397 (2008). 10.3858/emm.2008.40.4.387

[12]

Jung, D.I. et al. A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. J. Neurol. Sci. 285, 67–77 (2009). 10.1016/j.jns.2009.05.027

[13]

Bai, L. et al. Human bone marrow-derived mesenchymal stem cell induce Th2 polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57, 1192–1203 (2009). 10.1002/glia.20841

[14]

Rafei, M., Birman, E., Forner, K. & Galipeau, J. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol. Ther. 17, 1799–1803 (2009). 10.1038/mt.2009.157

[15]

Tanaka, F. et al. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci. 83, 771–779 (2008). 10.1016/j.lfs.2008.09.016

[16]

Barhum, Y. et al. Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J. Mol. Neurosci. 41, 129–137 (2010). 10.1007/s12031-009-9302-8

[17]

Krampera, M. et al. Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone 40, 382–390 (2007). 10.1016/j.bone.2006.09.006

[18]

Michalopoulos, G.K. Liver regeneration: molecular mechanisms of growth control. FASEB J. 4, 176–187 (1990). 10.1096/fasebj.4.2.2404819

[19]

Achim, C.L. et al. Expression of HGF and cMet in the developing and adult brain. Brain Res. Dev. Brain Res. 102, 299–303 (1997). 10.1016/s0165-3806(97)00108-9

[20]

Sulpice, E. et al. Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biol. Cell 101, 525–539 (2009). 10.1042/bc20080221

[21]

Kitamura, K. et al. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J. Neurosci. Res. 85, 2332–2342 (2007). 10.1002/jnr.21372

[22]

Anan, F. et al. Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis. Metabolism 56, 593–598 (2007). 10.1016/j.metabol.2007.01.003

[23]

Deuse, T. et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 120, S247–S254 (2009). 10.1161/circulationaha.108.843680

[24]

Sheth, P.R., Hays, J.L., Elferink, L.A. & Watowich, S.J. Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation. Biochemistry 47, 4028–4038 (2008). 10.1021/bi701892f

[25]

Sonnenberg, E., Meyer, D., Weidner, K.M. & Birchmeier, C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123, 223–235 (1993). 10.1083/jcb.123.1.223

[26]

Ishiki, Y., Ohnishi, H., Muto, Y., Matsumoto, K. & Nakamura, T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16, 1227–1235 (1992). 10.1002/hep.1840160520

[27]

Polisetti, N. et al. Gene expression profile of epithelial cells and mesenchymal cells derived from limbal explant culture. Mol. Vis. 16, 1227–1240 (2010).

[28]

Wang, Y. et al. MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells. Am. J. Physiol. Cell Physiol. 297, C1284–C1293 (2009). 10.1152/ajpcell.00183.2009

[29]

Ebens, A. et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17, 1157–1172 (1996). 10.1016/s0896-6273(00)80247-0

[30]

Yan, H. & Rivkees, S.A. Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J. Neurosci. Res. 69, 597–606 (2002). 10.1002/jnr.10323

[31]

Bottaro, D.P. et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802–804 (1991). 10.1126/science.1846706

[32]

Sun, W., Funakoshi, H. & Nakamura, T. Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. Brain Res. Mol. Brain Res. 103, 36–48 (2002). 10.1016/s0169-328x(02)00168-7

[33]

van der Horst, E.H. et al. Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivo. Neoplasia 11, 355–364 (2009). 10.1593/neo.81536

[34]

Bai, L., Caplan, A., Lennon, D. & Miller, R.H. Mesenchymal stem cell signals regulate neural stem cell fate. Neurochem. Res. 32, 353–362 (2007). 10.1007/s11064-006-9212-x

[35]

Gerdoni, E. et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61, 219–227 (2007). 10.1002/ana.21076

[36]

Siatskas, C., Payne, N.L., Short, M.A. & Bernard, C.C. A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it′s time!. Stem Cell Rev. 4, 500–506 (2010). 10.1007/s12015-010-9173-y

[37]

Birchmeier, C. & Gherardi, E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8, 404–410 (1998). 10.1016/s0962-8924(98)01359-2

[38]

Koç, O.N. et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 30, 215–222 (2002). 10.1038/sj.bmt.1703650

[39]

Kuroiwa, T. et al. Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J. Clin. Invest. 107, 1365–1373 (2001). 10.1172/jci11808

[40]

Futamatsu, H. et al. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ. Res. 96, 823–830 (2005). 10.1161/01.res.0000163016.52653.2e

[41]

Benkhoucha, M. et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 107, 6424–6429 (2010). 10.1073/pnas.0912437107

[42]

Karussis, D. & Kassis, I. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience. Clin. Neurol. Neurosurg. 110, 889–896 (2008). 10.1016/j.clineuro.2008.02.008

[43]

Di Renzo, M.F. et al. Selective expression of the Met/HGF receptor in human central nervous system microglia. Oncogene 8, 219–222 (1993).

[44]

Ghasemlou, N., Jeong, S.Y., Lacroix, S. & David, S. T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS. Glia 55, 294–302 (2007). 10.1002/glia.20449

[45]

Remyelination in the CNS: from biology to therapy

Robin J. M. Franklin, Charles ffrench-Constant

Nature Reviews Neuroscience 2008 10.1038/nrn2480

[46]

Pan, W. et al. Permeation of hepatocyte growth factor across the blood-brain barrier. Exp. Neurol. 201, 99–104 (2006). 10.1016/j.expneurol.2006.03.026

[47]

Miller, R.H. & Fyffe-Maricich, S.L. Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models. Dis. Model. Mech. 3, 535–539 (2010). 10.1242/dmm.001958

[48]

Hayashi, S. et al. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem. Biophys. Res. Commun. 220, 539–545 (1996). 10.1006/bbrc.1996.0440

[49]

Kerstetter, A.E., Padovani-Claudio, D.A., Bai, L. & Miller, R.H. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp. Neurol. 220, 44–56 (2009). 10.1016/j.expneurol.2009.07.010

[50]

Lennon, D.P. & Caplan, A.I. Isolation of human marrow-derived mesenchymal stem cells. Exp. Hematol. 34, 1604–1605 (2006). 10.1016/j.exphem.2006.07.014

Cited By

366

Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells

Madina Sarsenova, Yevgeniy Kim · 2022

Frontiers in Immunology

Secretome of Mesenchymal Stem Cells from Consecutive Hypoxic Cultures Promotes Resolution of Lung Inflammation by Reprogramming Anti-Inflammatory Macrophages

Zhihong Xu, Lulu Lin · 2022

International Journal of Molecular...

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Yufang Shi, Qing Li · 2018

Nature Reviews Nephrology

Mesenchymal stem cell‐derived factors: Immuno‐modulatory effects and therapeutic potential

Vladislav Volarevic, Marina Gazdic · 2017

BioFactors

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

Jacques Galipeau, Mauro Krampera · 2016

Cytotherapy

The immunomodulatory function of mesenchymal stem cells: mode of action and pathways

Antonio Uccelli, Nicole Kerlero de Rosbo · 2015

Annals of the New York Academy of S...

Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications

Ying Wang, Xiaodong Chen · 2014

Nature Immunology

How stem cells speak with host immune cells in inflammatory brain diseases

Stefano Pluchino, Chiara Cossetti · 2013

Glia

Metrics

366

Citations

50

References

Details

Published: May 20, 2012
Vol/Issue: 15(6)
Pages: 862-870
License: View

Authors

Department of Biology, Skeletal Research Center &, Center for Multimodal Evaluation of Engineered Cartilage Case Western Reserve University Cleveland OH 44106 USA

Cite This Article

Lianhua Bai, Donald P Lennon, Arnold I Caplan, et al. (2012). Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models. Nature Neuroscience, 15(6), 862-870. https://doi.org/10.1038/nn.3109

Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models

You May Also Like